Abstract
BackgroundAdoptive immunotherapy using chimeric antigen receptor (CAR) is recently reported as one of the effective cancer therapy. Especially CAR-T cell therapy targeting CD19 antigen in B-cell tumors have shown impressive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have